Clinical chemists relate the chemical composition of tissue and body fluids to different illnesses--a critical step in the diagnosis and treatment of diseases. For them, as for investigators in most other fields today, transforming an idea into reality requires extensive funding.

Sylvia Daunert, an assistant research professor at the University of Kentucky, is conducting research involving time-resolved fluorescence, creating more selective and sensitive assays for biomolecules and other biological compounds by using complexes of certain elements, such as europium, with fluorescent compounds. These complexes will fluoresce longer than compounds in existing biological and clinical samples and will bind either with antibodies or with the biomolecule being studied. This causes the fluorescent properties of the compound to be delayed, hence the name "time-resolved fluorescence."

Daunert was one of two recipients of $5,000 grants awarded last year by the Van Slyke Society, the philanthropic branch of the 40-year-old American Association for Clinical...

Interested in reading more?

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?